These changes have been reported for the "initial" (1-to 3-h) and "late" (18-to 20-h) postexposure periods. We hypothesized that at the late period, when protein and cellular markers of inflammation at the airway surface remain abnormal and the integrity of the epithelial barrier is compromised, bronchial reactivity would be increased. To test this, we measured airway responsiveness to cumulative doses of methacholine (MCh) aerosol in healthy subjects 19 Ϯ 1 h after a single exposure to O 3 (130 min at ambient levels between 120 and 240 parts/billion and alternate periods of rest and moderate exercise) or filtered air. Exposures were conducted at two temperatures: mild (22°C) and moderate (30°C). At the late period, bronchial reactivity to MCh increased, i.e., interpolated dose of MCh leading to a 50% fall in specific airway conductance (PC 50 ) was less after O 3 than after filtered air. PC 50 for O 3 at 22°C was 27 mg/ml (20% less than the PC 50 after filtered air), and for O 3 at 30°C it was 19 mg/ml (70% less than the PC 50 after filtered air). The forced expiratory volume in 1 s (FEV 1 ) at the late time point after O 3 was slightly but significantly reduced (2.3%) from the preexposure level. There was no relationship found between the functional changes observed early after exposure to O 3 and subsequent changes in bronchial reactivity or FEV 1 at the late time point. These results suggest that bronchial reactivity is significantly altered ϳ1 day after O 3 ; this injury may contribute to the respiratory morbidity that is observed 1-2 days after an episode of ambient air pollution. specific airway conductance; methacholine OZONE (O 3 ), a highly reactive gas, is a natural constituent of the upper atmosphere and is a major component of ambient smog formed by the reaction of primary air pollutants (hydrocarbons and oxides of nitrogen) in the presence of sunlight. An edemagenic lung irritant, O 3 affects the conducting airways and alveolar regions. Toxicity of O 3 to epithelial surfaces is primarily attributed to reactive oxygen species and ozonation of unsaturated fatty acids present in lung lining fluids (29) . Early (3-h) and late (18-to 20-h) responses in the human after whole lung exposure to O 3 include an influx of protein, inflammatory cells, and mediators into airway and alveolar surface fluids (2, 4, 35) . The presence of these cellular and biochemical markers of injury at the epithelial surface and the increased diffusivity of small molecules within the submucosa postexposure (14) have led to speculation that exposure to O 3 modulates bronchial smooth muscle tone and responsiveness to nonspecific challenge (24) .
Airway hyperresponsiveness is present in all humans with asthma, at least when symptomatic. The long-term effect(s) of increased airway responsiveness are unknown, although it may be a risk factor for the development of chronic obstructive lung disease (34) . Increased airway smooth muscle tone can lead to nonhomogeneous ventilation and limit the maximum oxygenation of pulmonary blood; both of these physiological responses may be exacerbated by O 3 (13, 33) . The extent to which O 3 affects airway responsiveness is unclear. Whereas an ambient level of O 3 does not provoke airway hyperresponsiveness either immediately or 24 h postexposure (26) , increases in airway responsiveness have been observed in the immediate postexposure period when O 3 has been combined with heavy exercise (22) or after high effective concentrations [400-600 parts/billion (ppb)] (21, 25, 32) . The duration of changes in airway reactivity after exposure to high concentrations (Ն400 ppb) of O 3 has not been determined. A recent study of asthmatic and healthy subjects exposed to 400 ppb O 3 has reported that airway hyperreactivity was present at a time point at least 12 h postexposure (20) . Moreover, an earlier investigation reported that, even with high levels of O 3 , provocative responses to nonspecific aerosol challenge return to baseline responsivity (preexposure) by 24 h (21). However, in several chamber studies, inflammation is present in airway and pulmonary tissues 24 h postexposure (2, 35) , and many epidemiological studies have documented that a lag time of 1-2 days follows acute episodes of oxidant air pollution before morbidity effects are observed (28, 36) .
The purpose of our study was to test the hypothesis that ambient levels of O 3 when combined with ambient temperature conditions can induce a state of airway hyperresponsiveness ϳ1 day postexposure. As a first step, we used a crossover design to expose healthy, nonasthmatic subjects to filtered air (FA) and O 3 at mild-and moderate-temperature conditions. Approximately 1 day after exposure, we evaluated nonspecific hyperresponsiveness of the subjects to cumulative challenge doses of methacholine (MCh) aerosol.
METHODS
Subject description and characterization. Nine healthy subjects (4 women and 5 men) were recruited for the study. All were nonsmokers, without a history of lung disease, and not receiving medications for any other disease. Age, anthropometric characteristics, and spirometric lung function values of the subjects are listed in Table 1 . The subjects had a mean age of 26 Ϯ 2 (SD) yr and were free of respiratory infection at the time of the evaluations. Subjects' mean values of the forced vital capacity (FVC), the forced expiratory volume in 1 s (FEV 1 ), and the midmaximal expiratory flow rate (FEF ) were Ͼ92 Ϯ 11% (SD) of predicted. Consent was obtained from the subjects before admission to the study, and the research had the approval of the University Human Research Review Board.
Experimental protocol. An initial (baseline) evaluation of pulmonary function and the treadmill (model Q55, Quinton Instruments, Seattle, WA) exercise required to attain cumulative ventilation per minute during exercise that was approximately equal to eight times the volume of the FVC was conducted on each subject. On 4 additional study days, the subjects returned to the laboratory at an appointed time and were exposed for a 130-min period to either FA or O 3 in a walk-in chamber facility (14.2 m 3 ). For each exposure (FA and O 3 ), chamber air was held at 45-55% relative humidity and at a mean temperature of either 22 or 30°C. Exposure of a given subject commenced at the same time of the day; the order for crossover of the exposures (FA at 22°C, FA at 30°C, O 3 at 22°C, O 3 at 30°C) was randomized with a minimum 10-day interval between the reexposure study days. Spirometry (at least 3 determinations) was measured before exposure, at midexposure, and at 10 min postexposure, and measurements of specific airway conductance (sGaw) and thoracic gas volume were accomplished at the before-exposure and 10-min postexposure assessment times by using a body plethysmographic method (Sensor Medics, Anaheim, CA) (7); spirometric and plethysmographic measures were repeated 18-20 h (ϳ1 day) postexposure. Immediately after these functional measures at ϳ1 day postexposure, the measurement of airway hyperresponsiveness to cumulative MCh aerosol challenge was assessed.
Methods of exposure. The chamber exposure facility has been described previously (14) . Air transport to the chamber was prefiltered and had a one-pass design with 30 changes of chamber air/h. Chamber O 3 , which was continuously monitored by an ultraviolet O 3 photometer (model 1003-AH, Dasibi, Glendale, CA), was generated from a 100% O 2 source by a high-frequency electric field (model G1-L, PCI Ozone, West Caldwell, NJ) and mixed with the FA supply before being added to the chamber. During the O 3 exposures, a standard concentration regimen was used, i.e., initiated at 120 ppb, ramped to 240 ppb, and then returned to the starting concentration by the conclusion of the exposure regimen. A ramped or pyramid-shaped profile of O 3 concentrations during exposure has been utilized previously (11, 14, 16) and is selected as an exposure plan that realistically resembles urban conditions (product of concentration ϫ time for our exposure plan would be equivalent to 130 min of O 3 exposure at a single concentration of 175 ppb). For the initial 120 min of each exposure, a subject alternated between 10-min periods of rest and mild treadmill exercise; exposures concluded with an additional 10 min of exposure under rest conditions. The treadmill speed and grade necessary to obtain the targeted minute ventilation, i.e., cumulative ventilation per minute during exercise that was approximately equal to eight times the volume of the FVC, were predetermined on the baseline visit before commencement of exposures. Exercise is frequently used during chamber exposures to increase minute ventilation to mimic an individual performing light activity under ambient conditions.
During exposure a subject could freely choose between nasal, oral, or oronasal breathing modes except for a 2-min period to assess minute ventilation during exercise periods when oral breathing and expiration into a dry-gas meter (American Meter, Philadelphia, PA) was obligatory.
MCh challenge. Approximately 18-20 h postexposure, the subjects returned to the laboratory for assessment of airway responsiveness to buffered MCh aerosol. For bronchoprovocation testing with MCh aerosol, the subjects were initially challenged with saline (0.9%) aerosol, followed by increasing doses of MCh diluted in 0.9% saline. MCh chloride (Sigma Chemical, St. Louis, MO) solutions were made up fresh for each test challenge. For saline and each MCh dose, the subjects inhaled five aerosol breaths starting at rest (functional residual capacity) position and inhaling an inspiratory capacity breath, followed by a 5-s breath hold at full inspiration and then a slow exhalation. To favor aerosol delivery, the subjects were assisted in maintaining the inspiratory flow at Ͻ0.4 l/s during the aerosol inhalation by a visual airflow indicator (model Elektro-2, Respiratory Care Center). MCh aerosol was generated by a jet nebulizer (model 646, DeVil- biss) powered with FA at 30 psi; nebulization of MCh for each challenge breath commenced after the subjects inspired a 150-ml volume and lasted for 0.6 s. The starting dose level of MCh was 2.5 mg/ml, which was then increased on each subsequent challenge to a maximal level of 22.5 mg/ml. After the fifth aerosol breath at each MCh dose, subjects relaxed for 3 min and then had spirometric and plethysmographic responses measured for each cumulative MCh dose inhaled.
The subjects did not demonstrate changes in spirometric flows, and therefore airway responsiveness was determined as the cumulative MCh dose leading to a decrease in the sGaw of at least 50% from the value of the sGaw observed after the saline challenge. Statistical analysis. Pulmonary function volume measurements were corrected to body temperature and pressure of gas saturated with water vapor (BTPS), and the trials with the highest FVC and FEV 1 for preexposure, midexposure, end exposure, and ϳ1 day postexposure were utilized for statistical analysis. Means Ϯ SE were calculated for spirometric function and plethysmographic measures with standard statistical methods. On the basis of the percent decrease from the reference value (0.9% saline) of the sGaw after each succeeding concentration of MCh, the following equation (1) was used to calculate the interpolated PC 50 (aerosol concentration of MCh leading to a 50% fall in the sGaw)
where C 1 is the second-to-last MCh concentration, C 2 is the final MCh concentration (concentration leading to a 50% or greater fall in sGaw), R 1 is the percent fall in sGaw after C 1 , and R 2 is the percent fall in sGaw after C 2 . Treatment (FA and O 3 ) effects on airway responses and responsivity to MCh aerosol challenge doses were compared with analysis of variance for repeated measures and a Newman-Keuls post hoc test for significance of the differences. A paired t-test was used to compare the differences between the means of the calculated PC 50 doses for the respective exposure conditions. A P value Ͻ0.05 was considered significant.
RESULTS
Measures of functional response. By design, during the exercise periods of each chamber exposure, a targeted minute ventilation was achieved. The mean minute ventilation attained by the subjects for the exercise periods are presented in Fig. 1 . Mean minute ventilations ranged between 36.40 Ϯ 0.5 (SE) and 38.7 Ϯ 1.0 l/min and were not significantly different between exposures. In general, during exposures to O 3 , the subjects reduced the depth of the tidal volume with a compensatory increase in the frequency of respiration, i.e., mean tidal volume during exercise periods for exposures to O 3 at 22 and 30°C were 1.84 and 1.72 liters compared with the mean tidal volumes of 2.02 and 1.89 liters for exposures to FA at the respective temperatures. The mean changes (before MCh challenge) in pulmonary function of the subjects after exposures to O 3 and FA for the different temperature conditions are presented in Fig. 2 . For the FVC and FEV 1 , the responses at midexposure and end exposure and at ϳ1 day postexposure are compared with the functional values observed preexposure. Reductions in the FVC and the FEV 1 were significant at midexposure and end exposure to O 3 (mean decrements were on the order of 2-7%) for both ambient temperature conditions (22 and 30 o C) compared with responses after FA exposure at the respective temperatures. The FEV 1 remained reduced at the 1-day-postexposure time point compared with the preexposure value; although the change was small, i.e., a mean decrease of 2.3% from the preexposure level, this reduction was significant. The FVC (Fig. 2 ) had recovered to baseline by the 1-day-postexposure time point.
Changes in the sGaw are presented in Fig. 3 ; only the change in the sGaw (mean fall of 13.4%) at the end-exposure time point for exposure to O 3 at an ambient temperature of 30°C was significant compared with the baseline sGaw and response to FA exposure at 30°C. There was a tendency for the sGaw to be elevated ϳ1 day postexposure, i.e., improved compared with the preexposure level; however, mean values of the sGaw were not significantly different from each other or from baseline values.
Measures of response to MCh challenge. At the 1-daypostexposure time point, the change in sGaw of the subjects to cumulative concentrations of MCh aerosol was a sensitive index for the assessment of airway responses. Measures of the FVC and the FEV 1 were not sensitive in our healthy subjects for assessing airway responsiveness to MCh challenge. Mean values of the change in the sGaw are compared in Fig. 4 for each exposure condition, and responses to succeeding doses of MCh are expressed as a percent change from the response to diluent, i.e., 0.9% saline. At the starting point of each MCh challenge, the sGaw was not significantly different from the preexposure value of the sGaw (see Fig. 3 ). Compared with the responses after exposure to FA, the airways were clearly more responsive to MCh after exposure to O 3 . sGaw at the highest MCh challenge concentration (22.5 mg/ml) for O 3 exposures and ambient temperature conditions of 22 and 30°C were significantly reduced compared with the corresponding FA exposures. There was the tendency for the sGaw response to MCh to be enhanced when O 3 was combined with the warmer exposure condition.
The interpolated PC 50 values of the subjects are listed in Table 2 for each exposure condition. The mean PC 50 calculated for exposures at 22°C was 20% less after O 3 than FA (27.4 vs. 34.1 mg/ml; P Ͻ 0.05), and for exposures at 30°C the mean PC 50 was further decreased, i.e., 70% less after O 3 than FA (19.3 vs. 66.2 mg/ml; P Ͻ 0.01).
DISCUSSION
This study in healthy adult nonsmokers demonstrates that airway hyperresponsiveness can be induced by O 3 exposure and measured ϳ1 day postexposure. Nonspecific aerosol challenge clearly demonstrated that the airways were hyperresponsive 1 day after exposure to O 3 compared with FA (P Ͻ 0.01). There was a tendency for the warmer exposure condition, i.e., 30 vs. 22°C, to enhance this response. As expected, mean spirometric indexes of airway function (e.g., FEV 1 ) were decreased significantly during and acutely after exposure to O 3 (P Ͻ 0.05), and on average the FEV 1 at 1 day postexposure had almost completely recovered (97.7% of the preexposure value; P Ͻ 0.05).
This is the first human study to characterize an O 3 -induced increase in airway responsiveness ϳ1 day postexposure. The subjects were exposed for 130 min to a ramped O 3 concentration (mean level of 175 ppb) at two ambient temperatures (22 and 30°C) and with a mild level of treadmill exercise. An additional functional index that was abnormal ϳ1 day postexposure was the FEV 1 , and although the response data were not included in the RESULTS, the FEF was similarly slightly and significantly reduced (mean decrease of 4.0%; P Ͻ 0.05) below the baseline values of the FEF recorded ϳ24 h earlier, preexposure to O 3 .
Our laboratory previously noted the failure of spirometric indexes of expiratory airflow to fully recover ϳ1 ; n ϭ 9 subjects. *Significant difference in percent change from the baseline value, P Ͻ 0.05. Fig. 4 . Cumulative methacholine aerosol dose-response curves ϳ1 day after exposure to FA and O 3 . Responses to succeeding doses of methacholine are compared with baseline response (i.e., zero dose, 0.00; diluent 0.9% saline) and expressed as percent change from baseline. Values are means Ϯ SE percent change from baseline response; n ϭ 8 subjects. *Significant difference compared with response of corresponding temperature condition and exposure to FA, P Ͻ 0.05. day postexposure to O 3 (15, 16) . In the present study, O 3 -induced changes in sGaw during cumulative MCh aerosol challenge did not correlate with delayed recovery in the FEV 1 or FEF . It has been suggested that changes in lung function during and immediately postexposure to O 3 are related to irritant and neural mechanisms (19, 27) , whereas the delayed changes in the FEV 1 and FEF 25-75 1 day postexposure may represent epithelial injury, receptor dysfunction, and inflammation at distal airway sites (14, 25) .
Increases in nonspecific airway responsiveness have been observed acutely postexposure (immediately to 12 h after exposure) in healthy subjects exposed to O 3 . These changes in airway reactivity have been reported for both low ambient (120-240 ppb) and high effective (400-600 ppb) chamber concentrations of O 3 (5, 21, 32) . The acute development of airway hyperreactivity may be vagally mediated, and the responsiveness can be reversed with atropine premedication (18, 21) . Investigations have utilized single-or multiple-exposure plans (9, 22) ; however, assessments of hyperreactivity were not usually conducted at later time points (i.e., 1 day postexposure) when O 3 -induced inflammation of the airways and lung parenchyma have been well characterized (11) . In one study of healthy subjects, an O 3 concentration of 200 ppb did not provoke airway responsiveness either immediately or 1 day postexposure (26) , although hyperresponsive airways have been reported after exposure to high concentrations (400-600 ppb) of O 3 (18, 32) . The duration of changes in airway reactivity after exposure to high effective concentrations (Ն400 ppb) of O 3 is also not certain. Airway hyperreactivity was found at a time point at least 12 h postexposure in asthmatic and healthy subjects exposed to 400 ppb O 3 (20) ; however, an earlier investigation suggested that, even at high concentrations of O 3 , airway responsiveness to either histamine or MCh aerosol returns to baseline responsivity (preexposure) within 24 h (18). Our results in healthy subjects demonstrate that airway hyperresponsiveness to MCh was clearly present 1 day postexposure. Airway conductance measures in our subjects had returned to baseline values at the start of the MCh challenge. Airway responsiveness to cumulative MCh challenge was significantly increased by exposure to O 3 at both the 22 or 30°C exposure temperatures, and there was a tendency for O 3 in combination with warmer exposure conditions to induce a greater degree of airway responsiveness. Similar to other phenotypic markers of O 3 exposure (2, 16, 31) , a range in sensitivity of the airway response to O 3 was present from no change in airway reactivity (subject 9) to a Ͼ50% decrease of the PC 50 (subject 4). We are uncertain why our results using ambient levels of O 3 (120-240 ppb) induced responsiveness 1 day postexposure, whereas investigations using higher effective concentrations of O 3 did not find airway hyperreactivity to be increased at a similar time postexposure (18) . Differences in protocol design existed because our protocol evaluated airway reactivity by using cumulative doses of an agonist at a single time point, ϳ1 day postexposure, whereas prior investigations may have assessed reactivity immediately and 1 day postexposure. A potentially confounding factor in serial measurements to assess airway responsiveness is that an initial provocative challenge may alter the response to a subsequent challenge (3) .
It has been previously demonstrated that exposure to FA at moderate differences in ambient temperature (20-30°C) did not alter spirometric indexes of airway function; however, when normal subjects exercised under hot, humid conditions (37°C and 60% relative humidity), lung function improved significantly (8) . However, the benefit of ambient heat on airway function appears to be lost when heat stress is combined with a high effective concentration of O 3 . For example, similar to our results with ambient levels of O 3 , exposure to an O 3 concentration of 500 ppb at temperatures of 25 and 31°C induced significant but similar decrements in the FEV 1 (decreased by 8% from preexposure value); however, at still warmer temperatures, i.e., 40°C, the O 3 -induced decrease in the FEV 1 was even greater, with an average decrement of 13% (10) . For healthy subjects, heat stress alone would not be expected to cause these functional changes, but a warmer exposure condition would cause an increase in ventilation during exercise periods of the exposure. An increase in minute ventilation during exposure to O 3 would increase the O 3 dose delivered to the respiratory tract. As part of our experimental design, we controlled the level of treadmill exercise and monitored minute ventilation to attain and duplicate the levels of minute ventilation under the four exposure conditions (Fig. 1) . Thus the effects on airway responsiveness we observed with O 3 were not related to differences in minute ventilation during exercise periods of the exposures.
A number of mechanisms could initiate the O 3 -induced airway hyperreactivity we observed ϳ1 day postexposure. First, there may be an immediate effect of O 3 and the airways. Inasmuch as O 3 is highly reactive, it interacts immediately with the tissue or fluids with which it comes into contact, i.e., epithelial lining fluid or membranes of resident airway cells (macrophages Values are given in mg/ml. Interpolated provocative dose of methacholine leading to 50% decrease in the specific airway conductance (sGaw) (PC 50 ) was calculated by using equation given in METHODS. * Mean dose significantly less than the mean dose for filtered-air exposure at 22°C, P Ͻ 0.05. † Mean dose significantly less than the mean dose for filtered-air exposure at 30°C, P Ͻ 0.05. and epithelial cells) (11) . Because O 3 does not penetrate cells, it can lead to several pulmonary and nonpulmonary events, and a cascade mechanism has been proposed to account for its toxicity (29) . For example, O 3 reacts with unsaturated fatty acids at the air-tissue barrier to form lipid ozonation products that include aldehydes, hydroxyhydroperoxides, and Creigee ozonide; lipid by-products in turn can activate epithelial membrane lipases and release additional mediators onto the airway surface. Support for this sequence includes increased levels of mediators such as PGF 2␣ , proinflammatory cytokines, and reactive oxygen intermediates in airway fluids sampled ϳ24 h postexposure to O 3 (11) . These by-products and mediators may also upregulate transcription factors such as nuclear factor-B and proinflammatory genes (6) as well as modulate airway reactivity to nonspecific stimulation (24) .
In addition, desquamation and disruption of airway epithelial membranes by O 3 would increase accessibility of MCh and other inhaled irritants and cellular mediators to epithelial sensory nerves and the bronchial musculature (8) . In support of this mechanism, our laboratory previously reported that ϳ1 day after exposure of healthy subjects to O 3 there is a loss of epithelial integrity and an increase in airway permeability (14) . Other than a temporal association of the two responses (changes in airway responsiveness and epithelial permeability) being present at the same time point postexposure to O 3 , we do not have additional evidence linking the duration of airway responsiveness to the loss of epithelial integrity. In a large-animal model, however, we have found that O 3 -induced changes in airway permeability can persist for up to 7 days postexposure (12) . In addition, there is increasing evidence in animal models that O 3 -induced airway hyperreactivity is modulated in part by neuronal effects and impairment of M 2 muscarinic autoreceptors that are present on parasympathetic nerves in the lung and normally function to attenuate vagally induced bronchoconstriction (17) .
In summary, our study has shown that an increase in airway reactivity to nonspecific stimulation occurs ϳ1 day postexposure to O 3 in healthy subjects. There was a tendency for the airway responses to MCh to be enhanced by an elevation in temperature during exposure, and although significant, but slight, decrements in indexes of forced expiratory flow were also apparent ϳ1 day postexposure to O 3 , these spirometric changes were not associated with alterations in airway hyperresponsiveness. Effects of inhalable irritants on the pattern of breathing, i.e., rapid and shallow breaths, may be enhanced by hotter exposure conditions and shift regional deposition of O 3 into dependent airways (23) . Because frequently O 3 generation occurs during periods of increasing ambient temperature (30) , our study suggests that O 3 -induced airway responsiveness may be exacerbated during summer heat waves and causal to an increase in respiratory morbidity during episodes of oxidant air pollution.
